Maggie Cheung

Senior Director, Regeneron

Role
Senior Director, Health Economics and Outcomes Research at Regeneron
Location
Los Angeles, CA, US
LinkedIn followers
500 followers
Research & DevelopmentView LinkedIn profile

About Maggie Cheung

With multidisciplinary training in health economics, epidemiology, pharmacy, and pharmaceutical sciences, I have enjoyed working with fellow colleagues, clinicians, and payers, to understand the real world value of innovative medicines and optimize access to effective treatments for patients need. The most rewarding moments of my career are the times when knowing my work has had a positive impact, even the slightest sometimes, on the patients and their families\' quality of life.

Experience

  1. Senior Director, Health Economics and Outcomes Research

    Regeneron

    Nov 2019 — Present

    Regeneron\'s flagship products include EYLEA, an anti-VEGF drug used to treat retinal vein blockage and age-related macular degeneration, and Dupixent, a monoclonal antibody drug used to treat inflammatory diseases such as eczema, asthma and nasal polyps.

Education

  • Sichuan University

    Master of Science - MS

  • Sichuan University

    Bachelor of Science - BS

  • University of Illinois Chicago

    Doctor of Philosophy - PhD

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Maggie Cheung — Senior Director, Health Economics and Outcomes Research at Regeneron in Los Angeles, CA, US | Unifers